Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-15 SCHMERTZLER MICHAEL Director Grant or award +8,000 123,266
2024-02-15 SCHMERTZLER MICHAEL Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2024-02-15 Bell William F. Jr. Director Grant or award +4,000 10,333
2024-02-15 Bell William F. Jr. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 SOUTHWELL DAVID P Director Grant or award +4,000 14,500
2024-02-15 SOUTHWELL DAVID P Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 Okey Stephanie Director Grant or award +4,000 9,867
2024-02-15 Okey Stephanie Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 Gravier Pierre CHIEF FINANCIAL OFFICER Grant or award +19,000 52,700
2024-02-15 Gravier Pierre CHIEF FINANCIAL OFFICER Grant or award +3,100 55,800
2024-02-15 Gravier Pierre CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +47,500 47,500
2024-02-15 Golden Lee Scott CHIEF MEDICAL OFFICER Grant or award +20,000 57,914
2024-02-15 Golden Lee Scott CHIEF MEDICAL OFFICER Grant or award +2,600 60,514
2024-02-15 Golden Lee Scott CHIEF MEDICAL OFFICER Grant or award · Stock Option (Right to Buy) +50,000 50,000
2024-02-15 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award +70,000 230,475
2024-02-15 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +175,000 175,000
2024-02-15 Boulding Mark Elliott EXEC. VP AND CLO Grant or award +18,000 89,189
2024-02-15 Boulding Mark Elliott EXEC. VP AND CLO Grant or award +3,200 92,389
2024-02-15 Boulding Mark Elliott EXEC. VP AND CLO Grant or award · Stock Option (Right to Buy) +45,000 45,000
2024-02-15 Jacobson Allan Steven Director Grant or award +4,000 16,348

Page 34 of 41 · 804 trades